Healthcare pricing is opaque by design. Here's how it actually works: how prices get set, why network discounts can mislead, where the premium dollar goes, and why higher cost rarely means higher quality.
A premium isn't a random number. It's a forecast: an estimate of what the plan expects to pay in claims, plus the cost to run the plan. So when premiums rise, the real question is: why are claims rising?
It's a loop. Each turn feeds the next. Nothing here is anyone's fault. It's just how the model behaves when nobody changes the cost of the care itself.
Hospital prices, drug list prices, and new treatments climb year over year.
The plan pays more for the same group of people and the same conditions.
Next year's premium is set to cover the higher expected claims.
Without changing what care actually costs, next year starts the cycle again.
The lever most plans never pull is the cost of each claim. PR Health works on exactly that. Fair pricing and steering toward better-value care give the loop somewhere to slow down.
The large majority of every premium dollar pays for medical care and prescriptions. Administration is real, but it's the smaller slice. This is an industry-published reference, rounded for clarity.
Figures are rounded illustrative references drawn from publicly reported industry breakdowns, not PR Health's own book of business. Exact mix varies by plan, group, and year.
Expand any topic. Each one is written for someone seeing it for the first time.
Every hospital keeps a master price list, often called a chargemaster. The numbers on it are set by the hospital, not by a market, and they rarely reflect what care costs to deliver. Almost no one pays the full chargemaster price, but it's the starting point that nearly every discount is measured against.
That matters because the same service can carry very different list prices at different facilities. When the list price is high, even a deep discount can leave a bill that's high in absolute terms.
A network discount is a percentage off the hospital's own list price. Because the hospital sets that list price, a larger discount doesn't always mean a lower bill. A 50% discount off an inflated number can still exceed a smaller discount off a reasonable one.
A clearer way to judge a price is to compare it against a neutral, public benchmark. Medicare publishes what it pays for most services, and many fair-pricing approaches express prices as a multiple of that benchmark, a far more stable yardstick than a discount off a number the seller chose.
Generally, no. Published quality measures (infection rates, complication rates, readmissions, patient-safety scores) do not reliably track price. A higher-cost facility may score the same or worse than a lower-cost one on the specific procedure you need.
This is the single most useful thing to internalize: price and quality are two separate questions. The next lesson shows them side by side for the same procedure.
Medicare-plus pricing sets a claim at a transparent, defensible benchmark: Medicare's published rate plus a fair margin for the provider, instead of a hospital's self-set list price. Paired with direct contracts negotiated with high-value providers, it's designed to be reasonable for the provider and predictable for the plan, a number both sides can stand behind.
Those Medicare rates aren't arbitrary: they're built from cost data that facilities and providers themselves report, with a margin already factored in. Medicare-plus pricing then pays a set percentage above that rate, so the provider earns their reported costs plus margin and an additional amount on top.
For members, the practical effect is fewer surprises and a plan dollar that stretches further. For the plan, it's a way to pay for care based on what it should cost, not on where the list price happened to land.
These are widely reported industry figures shown for orientation, not PR Health results, and not a promise of any specific outcome.
See the same procedure at two facilities, and why the cheaper one can score higher.
